Cantor Fitzgerald Affirms Overweight on Tesla, $425 Price Target

Analyst: Andres Sheppard 1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$425
Outcome
Reached
on September 17, 2025
Cantor and Tesla logos

What the analyst said

Cantor Fitzgerald analyst Andres Sheppard reiterated an Overweight rating and $425 price target on Tesla (NASDAQ: TSLA).

“We are encouraged by management’s reaffirmation of: launch of Robotaxi in Texas in June (next month), and the introduction of a lower-priced vehicle in 1H25 (we expect initial price of ~$30,000 inclusive of tax credit), which could be timely given the likely negative impact to vehicle prices due to tariff implementation and the likely removal of the tax credit.

We are also encouraged by Musk’s comments on the Q1 call, that his “time at DOGE will be significantly reduced” starting in May, and that as a result, he plans to allocate more time to Tesla.

Other key material catalysts include: rollout of FSD in China (started in 1Q25), rollout of FSD in Europe (we expect 1H25, pending regulatory approval), high volume production of Optimus Bot (2026E), initial deliveries of Optimus to customers (we expect 2027E), and introduction of the Semi Truck (we expect SOP in 2026 and for TSLA to enter the self-driving trucking industry).

Separately, we continue to believe Tesla is better-positioned (relative to other OEMS) to mitigate the impact from tariffs, with global manufacturing facilities in the U.S., Germany, and China (given domestic sourcing and high degree of vertical integration).

Overall we continue to see future revenue upside from FSD, Robotaxi, Energy Storage & Deployment, and Optimus Bots to be fundamental to TSLA’s thesis over the long term.

However, we expect some near-term headwinds due to macro conditions, tariffs, Musk’s polarizing politics, and the likely removal of the EV Tax Credit (we expect in 4Q25/2026).

Next quarter, management expects to revise its 2025 automotive growth target (currently to “return to growth”) and/or its Energy Storage outlook of >50% YoY (grew >100% in FY24).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TSLA trades at $358. The 17 analysts who set a target in the last 3 months range from $24.86 to $500, with a median of $442. This $425 target is 4% below the median.

Since the note TSLA has moved +2% (from $350). The 12-month window closed on May 19, 2026.

Track record

This call✓ Target reached on September 17, 2025, 4 months after the note.

Firm track recordCantor: 79% of its 56 targets at least a year old were reached within 12 months (#15 of 26 firms); on Tesla, 6 of 7. Accuracy ranking →

Cantor on Tesla

Cantor price targets on Tesla

8 calls from April 28, 2025 to July 21, 2025. The target is back at $355, after moving between $355 and $425. The rating stayed Buy.

Cantor targetTSLA share price
  1. July 21, 2025Kept the $355 targetBuy$355
  2. July 14, 2025Kept the $355 targetBuy$355
  3. July 7, 2025Kept the $355 targetBuy$355
  4. June 16, 2025Kept the $355 targetBuy$355
  5. May 27, 2025Target cut from $425 (−16%)Buy$355
  6. May 19, 2025 This noteTarget raised from $355 (+20%)Buy$425
  7. May 12, 2025Kept the $355 targetBuy$355
  8. April 28, 2025Earliest call shownBuy$355
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.